Abstract

Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), expressed on P. falciparum-infected erythrocytes, is a major family of clonally variant targets of naturally acquired immunity to malaria. Previous studies have demonstrated that in areas where malaria is endemic, antibodies to infected erythrocytes from children with severe malaria tend to be more seroprevalent than antibodies to infected erythrocytes from children with nonsevere malaria. These data have led to a working hypothesis that PfEMP1 variants associated with parasite virulence are relatively conserved in structure. However, the longevity of such serologically conserved variants in the parasite population is unknown. Here, using infected erythrocytes from recently sampled clinical P. falciparum samples, we measured serological conservation using pools of antibodies in sera that had been sampled 10 to 12 years earlier. The serological conservation of infected erythrocytes strongly correlated with the expression of specific PfEMP1 subsets previously found to be associated with severe malaria. However, we found no association between serological conservation per se and disease severity within these data. This contrasts with the simple hypothesis that P. falciparum isolates with a serologically conserved group of PfEMP1 variants cause severe malaria. The data are instead consistent with periodic turnover of the immunodominant epitopes of PfEMP1 associated with severe malaria.

Highlights

  • Malaria is still a major cause of childhood illness and death in Africa

  • Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), an extremely diverse group of multidomain parasite molecules encoded by var genes [8], is thought to be the major parasite antigen on infected erythrocytes (IEs) and mediates IE binding to the host microvascular endothelium, resulting in parasite sequestration in host tissues and the multiorgan pathology associated with severe malaria

  • The following additional assays were performed for comparison: (i) a subset of the parasites was tested for reactivity with these serum sample pools by an agglutination assay, and (ii) parasite isolates were tested for reactivity with a panel of 15 previously described plasma samples from children with acute malaria collected in the study setting between 1994 and 1996 by both immunofluorescence assay (IFA) and an agglutination assay [3]

Read more

Summary

Introduction

Malaria is still a major cause of childhood illness and death in Africa. repeated exposure to infection results in the acquisition of naturally acquired immunity [1], underpinning ongoing efforts to develop effective vaccines and other interventions.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.